Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Journal of Chemical Ecology
|
July 10, 2013
Differential allocation of seed-borne ergot alkaloids during early ontogeny of morning glories (Convolvulaceae)
Wesley T Beaulieu, Daniel G Panaccione, Corey S Hazekamp, et al.
Translational Vision Science & Technology
|
September 1, 2023
Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
Clement K Chan, Wesley T Beaulieu, Brandon J Lujan, et al.
Translational Vision Science & Technology
|
May 18, 2021
Effect of Initial Aflibercept, Laser, or Observation on Low-Contrast Visual Acuity in Eyes With Diabetic Macular Edema and Good Vision: Ancillary Study Within a Randomized Clinical Trial
Wesley T Beaulieu, Adam R Glassman, Carl W Baker, et al.
Ophthalmology
|
July 8, 2018
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes
Susan B Bressler, Wesley T Beaulieu, Adam R Glassman, et al.
Retina (Philadelphia, Pa.)
|
February 27, 2019
PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Should Baseline Characteristics Affect Choice of Treatment?
Susan B Bressler, Wesley T Beaulieu, Adam R Glassman, et al.
American Journal of Ophthalmology
|
August 16, 2016
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial
Wesley T Beaulieu, Neil M Bressler, Michele Melia, et al.
Ophthalmology
|
February 6, 2017
Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab
Susan B Bressler, Wesley T Beaulieu, Adam R Glassman, et al.
JAMA Ophthalmology
|
February 3, 2018
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial
Neil M Bressler, Wesley T Beaulieu, Adam R Glassman, et al.
Retina (Philadelphia, Pa.)
|
February 2, 2023
DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMA
Jennifer K Sun, Wesley T Beaulieu, Michele Melia, et al.
Journal of Agricultural and Food Chemistry
|
April 4, 2013
Production of the alkaloid swainsonine by a fungal endosymbiont of the Ascomycete order Chaetothyriales in the host Ipomoea carnea
Daniel Cook, Wesley T Beaulieu, Ivan W Mott, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Journal of Chemical Ecology
|
July 10, 2013
Differential allocation of seed-borne ergot alkaloids during early ontogeny of morning glories (Convolvulaceae)
Wesley T Beaulieu, Daniel G Panaccione, Corey S Hazekamp, et al.
Translational Vision Science & Technology
|
September 1, 2023
Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
Clement K Chan, Wesley T Beaulieu, Brandon J Lujan, et al.
Translational Vision Science & Technology
|
May 18, 2021
Effect of Initial Aflibercept, Laser, or Observation on Low-Contrast Visual Acuity in Eyes With Diabetic Macular Edema and Good Vision: Ancillary Study Within a Randomized Clinical Trial
Wesley T Beaulieu, Adam R Glassman, Carl W Baker, et al.
Ophthalmology
|
July 8, 2018
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes
Susan B Bressler, Wesley T Beaulieu, Adam R Glassman, et al.
Retina (Philadelphia, Pa.)
|
February 27, 2019
PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Should Baseline Characteristics Affect Choice of Treatment?
Susan B Bressler, Wesley T Beaulieu, Adam R Glassman, et al.
American Journal of Ophthalmology
|
August 16, 2016
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial
Wesley T Beaulieu, Neil M Bressler, Michele Melia, et al.
Ophthalmology
|
February 6, 2017
Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab
Susan B Bressler, Wesley T Beaulieu, Adam R Glassman, et al.
JAMA Ophthalmology
|
February 3, 2018
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial
Neil M Bressler, Wesley T Beaulieu, Adam R Glassman, et al.
Retina (Philadelphia, Pa.)
|
February 2, 2023
DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMA
Jennifer K Sun, Wesley T Beaulieu, Michele Melia, et al.
Journal of Agricultural and Food Chemistry
|
April 4, 2013
Production of the alkaloid swainsonine by a fungal endosymbiont of the Ascomycete order Chaetothyriales in the host Ipomoea carnea
Daniel Cook, Wesley T Beaulieu, Ivan W Mott, et al.
Page
of 5